Scientific Presentations

Press releases
Corporate presentation
Scientific Presentations
Scientific Publications
Events and webcasts
Stock information
SEC filings
Financial Statements
Regulated information
Voting Rights & Share Capital
ATM Program
General meetings
Governance
The board and committee members
Corporate governance documents
FAQ
IR Inquiry
All 2024 2023 2022 2021
27 Oct 2021
09:15 E.S.T.

Preclinical development of a TALEN-based genome editing therapy for RAG1 deficiency - ESGCT 2021- Oral Presentation

Download the PDF file